Doxorubicin-Induced Vascular Toxicity – Targeting Potential Pathways May Reduce Procoagulant Activity

Por Ben Aharon, Irit, Bar Joseph, Hadas, Tzabari, Moran, Shenkman, Boris, Farzam, Nahid, Levi, Mattan, Shalgi, Ruth, Stemmer, Salomon M., Savion, Naphtali
Publicado em 2013